LGALS1 and schizophrenia: Given the relevance of many of the above-discussed downstream effects of the serine–glycine pathway for schizophrenia, serine and glycine and HPL have potential roles as biomarkers for schizophrenia, and preliminary research on their role in this disorder has indeed been reported in the literature [128].